Clinical trial
Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting
NCT07549607 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting
- Lead sponsor
- University of Leipzig
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 1, 2026
- Completion date
- October 1, 2028
- Enrollment
- 100 (estimated)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
primary bilary cirrhosis (pbc)